Stock Screener App

Frei -

Installieren

29.57

4.38% 1.24

after-market

Handel nachbörslich: 29.57

Rapport Therapeutics Inc (RAPP)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Rapport Therapeutics Inc-Aktie (RAPP)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00% -	20.00	-	-	-
Operating Expenses	37.52% 60.81	44.22	38.51	29.99	29.50
Operating Income/Loss	151.11% -60.81	-24.21	-38.51	-29.99	-29.50
Nonoperating Income/Loss	3.83% 4.191	4.358	4.746	3.061	2.764
Net Income/Loss	185.11% -56.62	-19.86	-33.76	-26.93	-26.73
Basic Average Shares	0.50% 47.47	47.24	2.7107	37.93	35.44
Diluted Average Shares	0.50% 47.47	47.24	2.7107	37.93	35.44
Basic Earnings Per Share	183.33% -1.19	-0.42	-0.71	-0.71	-0.75
Diluted Earnings Per Share	183.33% -1.19	-0.42	-0.71	-0.71	-0.75

ANAB

$48.71

4.37%

AAPG

$14.69

1.08%

OMER

$18.79

1.95%

RARE

$15.17

1.81%

INBX

$90.50

6.15%

INVA

$20.86

0.52%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters